GLP-1 Agonists for Obesity

Written By Diana L Sung

Join us for a special Stanford Med Matters YouTube premiere featuring experts in obesity treatment and GLP-1 receptor agonist therapies. Hosted by a distinguished panel of clinicians, this episode explores the history, current guidelines, and groundbreaking future of GLP-1 treatments for pediatric and adult populations. Gain valuable insights into how GLP-1 therapies have transformed the landscape of obesity management and patient outcomes, and hear exclusive recommendations for clinicians treating obesity as a complex metabolic disease. Don’t miss this opportunity—subscribe to the Stanford CME channel and set your reminders for the premiere now!

Diana L Sung
Previous

Can AI improve plant-based meats?
Next

Breakthrough Study by SDRC Investigator Jonathan Long Uncovers the Connection Between PTER and Taurine Metabolism in the Fight Against Obesity